Succinate-Binding Polypeptides and Use Thereof

Ehud Ohana

Succinate-Binding Polypeptides and Use Thereof

Ehud Ohana (Inventor)

Department of Clinical Biochemistry and Pharmacology

Ben-Gurion University of the Negev

Research output: Patent

Abstract

Polypeptides comprising an amino acid sequence of Slc26a6 or IRBIT comprising a mutation that increases NaDC-1 binding, stability of the polypeptide, stability of NaDC-1 complex or a combination thereof are provided. Polypeptides comprising an amino acid sequence of a mutant succinate receptor 1 (mutSUCNR1), comprising a mutation that increases succinate binding, stability of the polypeptide, stability of the mutSUCNR1-succinate complex or combinations thereof are also provided. Compositions comprising the polypeptides, nucleic acid molecules and vectors encoding the polypeptides, and methods of use of the polypeptides or compositions, specifically for treating succinate-associate diseases and conditions are also provided.

Original language	American English
Patent number	US20200262889A1
State	Published - 20 Aug 2020

Access to Document

https://patents.google.com/patent/US20200262889A1/en?oq=inventor:(Ehud+OHANA)+US20200262889A1#citedBy

Cite this

@misc{99c9b667833d4be88490d452097cae96,

title = "Succinate-Binding Polypeptides and Use Thereof",

abstract = "Polypeptides comprising an amino acid sequence of Slc26a6 or IRBIT comprising a mutation that increases NaDC-1 binding, stability of the polypeptide, stability of NaDC-1 complex or a combination thereof are provided. Polypeptides comprising an amino acid sequence of a mutant succinate receptor 1 (mutSUCNR1), comprising a mutation that increases succinate binding, stability of the polypeptide, stability of the mutSUCNR1-succinate complex or combinations thereof are also provided. Compositions comprising the polypeptides, nucleic acid molecules and vectors encoding the polypeptides, and methods of use of the polypeptides or compositions, specifically for treating succinate-associate diseases and conditions are also provided.",

author = "Ehud Ohana",

note = "US Patent App. 16/647,945; US20200262889A1",

year = "2020",

month = aug,

day = "20",

language = "American English",

type = "Patent",

}

TY - PAT

T1 - Succinate-Binding Polypeptides and Use Thereof

AU - Ohana, Ehud

N1 - US Patent App. 16/647,945

PY - 2020/8/20

Y1 - 2020/8/20

N2 - Polypeptides comprising an amino acid sequence of Slc26a6 or IRBIT comprising a mutation that increases NaDC-1 binding, stability of the polypeptide, stability of NaDC-1 complex or a combination thereof are provided. Polypeptides comprising an amino acid sequence of a mutant succinate receptor 1 (mutSUCNR1), comprising a mutation that increases succinate binding, stability of the polypeptide, stability of the mutSUCNR1-succinate complex or combinations thereof are also provided. Compositions comprising the polypeptides, nucleic acid molecules and vectors encoding the polypeptides, and methods of use of the polypeptides or compositions, specifically for treating succinate-associate diseases and conditions are also provided.

AB - Polypeptides comprising an amino acid sequence of Slc26a6 or IRBIT comprising a mutation that increases NaDC-1 binding, stability of the polypeptide, stability of NaDC-1 complex or a combination thereof are provided. Polypeptides comprising an amino acid sequence of a mutant succinate receptor 1 (mutSUCNR1), comprising a mutation that increases succinate binding, stability of the polypeptide, stability of the mutSUCNR1-succinate complex or combinations thereof are also provided. Compositions comprising the polypeptides, nucleic acid molecules and vectors encoding the polypeptides, and methods of use of the polypeptides or compositions, specifically for treating succinate-associate diseases and conditions are also provided.

M3 - Patent

M1 - US20200262889A1

ER -